News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Bedaquiline price protests hit World Lung Conference launch

    As the opening ceremony of the 49th Union World Conference on Lung Health kicked off in the Netherlands last night, protesting activists demanded Johnson & Johnson (J&J) slash its price for the blockbuster tuberculosis (TB) drug, bedaquiline.

    26 October 2018 | Health-e
  • Patients 'may need to stockpile own drugs if no-deal Brexit looms'

    Patients should consider stockpiling their own drugs if it looks likely the UK will leave the EU with no deal, the pharmaceuticals industry has said, telling MPs that such a scenario could be “catastrophic” for medicine supplies and necessitate emergency powers.

    23 October 2018 | The Guardian
  • Johnson & Johnson prices keep key TB medicines out of reach

    As US pharmaceutical corporation Johnson & Johnson (J&J) continues to charge high prices for its newer tuberculosis (TB) drug bedaquiline, people with drug-resistant tuberculosis (DR-TB) are forced to go without the best possible treatments, according to a new report—DR-TB Drugs Under the Microscope—released today by Doctors Without Borders/Médecins Sans Frontières (MSF) at the 49th Union World Conference on Lung Health in The Hague. J&J should cut the price of bedaquiline in half so more lives can be saved, said the international medical humanitarian organization MSF.

    23 October 2018 | MSF
  • The health innovation system is ‘broken’ and failing patients

    NHS patients are being let down by a global health innovation system which fails to deliver the treatments they need at prices that government can afford, according to a new report led by Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment.

    18 October 2018 | STOP AIDS
  • South Africa: Shortage of HIV/Aids drugs turning into ‘national crisis’

    ARVs and contraceptives have run out across the country in ‘a crisis that has been developing over the past two months’, the Stop Stockout Project claims.

    16 October 2018 | The Citizen
  • Impatient patients turn to online 'buyers club' for new drugs

    Frustrated by delays in new medicines reaching their own country, a small but growing number of patients are turning to an online broker that bills itself as a legal version of the Dallas Buyers Club. While regulators warn of the risk of buying drugs online, the Amsterdam-based Social Medwork sees its network of trusted suppliers as filling a gap in the market for the latest drugs against diseases such as cancer, migraine and multiple sclerosis.

    03 October 2018 | Reuters
  • Desperate border crossings, as Venezuela runs short of HIV drugs

    Venezuela's economic meltdown has triggered the biggest exodus of people in modern Latin American history.

    03 October 2018 | Reuters
  • Community ART groups: bringing HIV treatment closer to patient's homes and to communities in conflict

    Charles Ssonko of Médecins sans Frontières describes the role of community groups in maintaining access to antiretroviral drugs for patients in Central African Republic, even under the most difficult and dangerous circumstances.

    03 October 2018 | PLoS Blogs
  • Fears over HIV drugs in event of ‘no deal’ Brexit

    Healthcare advocates highlight concerns over slower access to the newest HIV drugs when the UK leaves the European Union next year

    02 October 2018 | Gay Star News
  • Brexit, health care, and life sciences: plan for the worst

    Negotiations continue between the UK and the EU27 for Brexit plans. Deal or no deal, leaders in health care, pharmaceutical, and life sciences are covering all bases. Becky McCall reports.

    28 September 2018 | The Lancet (requires free registration)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.